Syndax Pharmaceuticals, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2022-03-01: Form 10-K; Item Smaller reporting company; As filed Yes.
- 2021-11-15: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2021-11-15: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2021-08-09: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2022-03-01 | 10-K | Smaller reporting company | Yes |
| 2021-11-15 | 10-Q | Smaller reporting company | Yes |
| 2021-11-15 | 10-Q | Emerging growth company | Yes |
| 2021-08-09 | 10-Q | Smaller reporting company | Yes |
| 2021-08-09 | 10-Q | Emerging growth company | Yes |
| 2021-05-11 | 10-Q | Smaller reporting company | Yes |
| 2021-05-11 | 10-Q | Emerging growth company | Yes |
| 2021-04-30 | 10-K/A | Smaller reporting company | Yes |
| 2021-04-30 | 10-K/A | Emerging growth company | Yes |
| 2021-03-12 | 10-K | Smaller reporting company | Yes |
| 2021-03-12 | 10-K | Emerging growth company | Yes |
| 2020-11-05 | 10-Q | Smaller reporting company | Yes |
| 2020-11-05 | 10-Q | Emerging growth company | Yes |
| 2020-08-06 | 10-Q | Smaller reporting company | Yes |
| 2020-08-06 | 10-Q | Emerging growth company | Yes |
| 2020-05-07 | 10-Q | Smaller reporting company | Yes |
| 2020-05-07 | 10-Q | Emerging growth company | Yes |
| 2020-03-05 | 10-K | Smaller reporting company | Yes |
| 2020-03-05 | 10-K | Emerging growth company | Yes |
| 2020-03-05 | 10-K | Well-known seasoned issuer | No |
| 2019-11-07 | 10-Q | Smaller reporting company | Yes |
| 2019-11-07 | 10-Q | Emerging growth company | Yes |
| 2019-08-07 | 10-Q | Smaller reporting company | Yes |
| 2019-08-07 | 10-Q | Emerging growth company | Yes |
| 2019-05-08 | 10-Q | Smaller reporting company | Yes |
| 2019-05-08 | 10-Q | Emerging growth company | Yes |
| 2019-03-07 | 10-K | Smaller reporting company | Yes |
| 2019-03-07 | 10-K | Emerging growth company | Yes |
| 2019-03-07 | 10-K | Well-known seasoned issuer | No |
| 2018-11-05 | 10-Q | Smaller reporting company | Yes |
| 2018-11-05 | 10-Q | Emerging growth company | Yes |
| 2018-03-08 | 10-K | Well-known seasoned issuer | No |
| 2017-03-14 | 10-K | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |